Sponsor or institution
Clinical trials and research at Virogenomics Biodevelopment, INC.
As of November 12, 2026, Find a Trial lists 4 NIH-funded research projects at this institution, with $7.4 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4NIH research projects
NIH-funded research (4)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
DRhQ: a new drug targeting CD74 for methamphetamine addiction
Testing DRhQ, a new medicine that aims to reduce cravings, brain inflammation, and relapse in adults with methamphetamine (stimulant) use disorder.
-
DRhQ: a new approach to protect brain cells after drug-related injury by targeting CD74 signaling
A new treatment called DRhQ aims to reduce brain damage from non-disordered drug use, using a molecule that calms inflammation and supports white-matter health in affected individuals.
-
Testing a new treatment for methamphetamine addiction
This study is testing a new treatment for people dealing with methamphetamine addiction, using a special molecule to see if it can help reduce cravings and improve thinking skills, and it's looking for both healthy volunteers and those with addiction to participate.
-
Targeting CD74 to treat stimulant use disorder
This study is looking at a new treatment for people struggling with methamphetamine addiction by testing a special molecule that might help reduce cravings and improve thinking skills, aiming to offer hope where other treatments haven't worked.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.